Latest Articles

Publication Date
All News Scientific
Dylan Sprouse Supports Wife Barbara Palvins Health Condition By Wearing Yellow Ribbon Pin At Victorias - Free Press Journal

Dylan Sprouse Supports Wife Barbara Palvins Health Condition By Wearing Yellow Ribbon Pin At Victorias Free Press Journal

Published: Oct. 18, 2025, 11 a.m.
Read Full Article
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - The AI Journal

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen The AI Journal

Published: Oct. 18, 2025, 10:28 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - The AI Journal

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer The AI Journal

Published: Oct. 18, 2025, 10:20 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - GlobeNewswire

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer GlobeNewswire

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen - Business Wire

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen Business Wire

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Yahoo Finance

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Yahoo Finance

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
The best October Prime Day 2025 Satisfyer deals - Mashable

The best October Prime Day 2025 Satisfyer deals Mashable

Published: Oct. 18, 2025, 8:13 a.m.
Read Full Article
Women's health campaigner calls for medical professionals to believe Black women when they raise concerns about reproductive issues - voice-online.co.uk

Women's health campaigner calls for medical professionals to believe Black women when they raise concerns about reproductive issues voice-online.co.uk

Published: Oct. 17, 2025, 7:02 p.m.
Read Full Article
People are applauding Dylan Sprouse for his interview at the Victoria's Secret show - Anabel

People are applauding Dylan Sprouse for his interview at the Victoria's Secret show Anabel

Published: Oct. 17, 2025, 6:17 p.m.
Read Full Article
Dylan Sprouse Praised For Using Red Carpet To Raise Awareness About Endometriosis After Wife's Battle - Comic Sands

Dylan Sprouse Praised For Using Red Carpet To Raise Awareness About Endometriosis After Wife's Battle Comic Sands

Published: Oct. 17, 2025, 5:27 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!